King Pharmaceuticals®, Inc. Announces That It is Now Distributing Bicillin® C-R Manufactured at Its Michigan Facility

BRISTOL, Tenn.--(BUSINESS WIRE)--King Pharmaceuticals, Inc. (NYSE: KG) today announced that it has begun distributing Bicillin® C-R (penicillin G benzathine and penicillin G procaine injectable suspension) manufactured at the Company’s dedicated penicillin manufacturing facility in Rochester, Michigan.